AI-generated summary
The authors report a randomized, triple-blind, placebo-controlled trial of 112 breast cancer patients receiving doxorubicin-cyclophosphamide, comparing red and infrared laser treatment of the tongue with a simulated placebo. They found less objective and subjective taste loss and better quality of life in the treated group. The abstract does not describe long-term follow-up or the size of the effects.
- Participants
- 112
- Who or what was studied
- Women with breast cancer treated with doxorubicin-cyclophosphamide (AC) chemotherapy
- Limits stated in the abstract
- The abstract does not report effect sizes or long-term follow-up, and it is a single trial in one patient population.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 2 J, 3 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Laser, Trial registration, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.